Breaking News

Warnex To Sell Analytical Services Biz

Undisclosed buyer picks up QC services for $1.1 million, plus considerations

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Warnex has entered into a binding agreement with a private, undisclosed company to sell its wholly-owned Analytical Services division. The unit provides a variety of quality control services, including chemistry, chromatography, microbiology, method development and validation, and stability studies. Warnex will receive $400,000 in cash, a cash payment equal to the working capital of the division — approximately $700,000 — on the Closing Date, a 15% passive equity interest in the pur...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters